Latest Insider Transactions at Schrodinger, Inc. (SDGR)
This section provides a real-time view of insider transactions for Schrodinger, Inc. (SDGR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Schrodinger, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Schrodinger, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
225,392
-0.59%
|
$22,764,592
$101.22 P/Share
|
Feb 17
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,000
-0.07%
|
$4,770,000
$106.41 P/Share
|
Feb 16
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private sale
|
Direct |
5,574
-69.61%
|
$618,714
$111.61 P/Share
|
Feb 16
2021
|
Joel Lebowitz EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,574
+50.0%
|
$22,296
$4.34 P/Share
|
Feb 11
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-1.27%
|
$212,000
$106.07 P/Share
|
Feb 11
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,800
-100.0%
|
$296,800
$106.07 P/Share
|
Feb 11
2021
|
Cony D'Cruz EVP & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
$8,400
$3.07 P/Share
|
Feb 11
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,007
-23.08%
|
$212,742
$106.07 P/Share
|
Feb 11
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,007
+18.75%
|
$34,119
$17.0 P/Share
|
Feb 10
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,007
-23.08%
|
$210,735
$105.46 P/Share
|
Feb 10
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,007
+18.75%
|
$34,119
$17.0 P/Share
|
Feb 09
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,006
-23.07%
|
$208,624
$104.81 P/Share
|
Feb 09
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,006
+18.75%
|
$34,102
$17.0 P/Share
|
Feb 08
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,006
-23.07%
|
$200,600
$100.0 P/Share
|
Feb 08
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,006
+18.75%
|
$34,102
$17.0 P/Share
|
Feb 05
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,006
-23.07%
|
$198,594
$99.8 P/Share
|
Feb 05
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,006
+18.75%
|
$34,102
$17.0 P/Share
|
Feb 05
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private purchase
|
Direct |
1,115
-100.0%
|
$110,385
$99.9 P/Share
|
Feb 05
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private sale
|
Direct |
11,259
-48.78%
|
$1,103,382
$98.54 P/Share
|
Feb 05
2021
|
Joel Lebowitz EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,374
+50.0%
|
$210,358
$17.0 P/Share
|
Feb 05
2021
|
Robert Lorne Abel Officer |
SELL
Open market or private sale
|
Direct |
15,873
-53.12%
|
$1,555,554
$98.84 P/Share
|
Feb 05
2021
|
Robert Lorne Abel Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,873
+45.34%
|
$31,746
$2.25 P/Share
|
Feb 03
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-1.26%
|
$188,000
$94.84 P/Share
|
Feb 03
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,800
-100.0%
|
$263,200
$94.84 P/Share
|
Feb 03
2021
|
Cony D'Cruz EVP & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
$8,400
$3.07 P/Share
|
Feb 01
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
418
-5.88%
|
$38,038
$91.2 P/Share
|
Feb 01
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
418
+5.56%
|
$1,672
$4.34 P/Share
|
Jan 19
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-1.24%
|
$182,000
$91.79 P/Share
|
Jan 19
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,800
-100.0%
|
$254,800
$91.79 P/Share
|
Jan 19
2021
|
Cony D'Cruz EVP & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
$8,400
$3.07 P/Share
|
Jan 14
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private sale
|
Direct |
5,574
-35.59%
|
$507,234
$91.27 P/Share
|
Jan 14
2021
|
Joel Lebowitz EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,574
+50.0%
|
$22,296
$4.34 P/Share
|
Jan 13
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-1.23%
|
$178,000
$89.64 P/Share
|
Jan 13
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,800
-100.0%
|
$249,200
$89.75 P/Share
|
Jan 13
2021
|
Cony D'Cruz EVP & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
$8,400
$3.07 P/Share
|
Jan 08
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-1.21%
|
$170,000
$85.3 P/Share
|
Jan 08
2021
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,800
-100.0%
|
$238,000
$85.3 P/Share
|
Jan 08
2021
|
Cony D'Cruz EVP & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
$8,400
$3.07 P/Share
|
Jan 04
2021
|
Jennifer Daniel EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
418
-5.88%
|
$33,022
$79.6 P/Share
|
Jan 04
2021
|
Jennifer Daniel EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
418
+5.56%
|
$1,672
$4.34 P/Share
|
Dec 23
2020
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-1.2%
|
$164,000
$82.21 P/Share
|
Dec 23
2020
|
Cony D'Cruz EVP & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,375
-100.0%
|
$358,750
$82.21 P/Share
|
Dec 23
2020
|
Cony D'Cruz EVP & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+50.0%
|
$13,125
$3.07 P/Share
|
Dec 22
2020
|
Michael Lynton Director |
SELL
Open market or private sale
|
Direct |
8,334
-100.0%
|
$708,390
$85.0 P/Share
|
Dec 22
2020
|
Michael Lynton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+50.0%
|
$33,336
$4.34 P/Share
|
Dec 22
2020
|
Shane Brauner EVP & CIO |
SELL
Open market or private sale
|
Direct |
2,000
-7.44%
|
$170,000
$85.0 P/Share
|
Dec 18
2020
|
Karen Akinsanya President of R&D, Therapeutics |
SELL
Open market or private sale
|
Direct |
13,377
-100.0%
|
$1,070,160
$80.0 P/Share
|
Dec 18
2020
|
Karen Akinsanya President of R&D, Therapeutics |
BUY
Exercise of conversion of derivative security
|
Direct |
13,377
+50.0%
|
$40,131
$3.22 P/Share
|
Dec 18
2020
|
Jenny Herman SVP & Controller |
SELL
Open market or private sale
|
Direct |
1,217
-99.75%
|
$97,360
$80.0 P/Share
|
Dec 18
2020
|
Michael Lynton Director |
SELL
Open market or private sale
|
Direct |
8,333
-100.0%
|
$666,640
$80.0 P/Share
|